BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 37131499)

  • 1. Software-Tool Support for Collaborative, Virtual, Multi-Site Molecular Tumor Boards.
    Schapranow MP; Borchert F; Bougatf N; Hund H; Eils R
    SN Comput Sci; 2023; 4(4):358. PubMed ID: 37131499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multicenter Comparison of Molecular Tumor Boards in The Netherlands: Definition, Composition, Methods, and Targeted Therapy Recommendations.
    Koopman B; Groen HJM; Ligtenberg MJL; Grünberg K; Monkhorst K; de Langen AJ; Boelens MC; Paats MS; von der Thüsen JH; Dinjens WNM; Solleveld N; van Wezel T; Gelderblom H; Hendriks LE; Speel EM; Theunissen TE; Kroeze LI; Mehra N; Piet B; van der Wekken AJ; Ter Elst A; Timens W; Willems SM; Meijers RWJ; de Leng WWJ; van Lindert ASR; Radonic T; Hashemi SMS; Heideman DAM; Schuuring E; van Kempen LC
    Oncologist; 2021 Aug; 26(8):e1347-e1358. PubMed ID: 33111480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of virtual molecular tumor boards for informed clinical decision-making.
    Angel M; Demiray M; Dişel U; Passos J
    Oncologist; 2024 May; ():. PubMed ID: 38761380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Data-driven support to decision-making in molecular tumour boards for lymphoma: A design science approach.
    Rodríguez Ruiz N; Abd Own S; Ekström Smedby K; Eloranta S; Koch S; Wästerlid T; Krstic A; Boman M
    Front Oncol; 2022; 12():984021. PubMed ID: 36457495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sharing clinical decisions for multimorbidity case management using social network and open-source tools.
    Martínez-García A; Moreno-Conde A; Jódar-Sánchez F; Leal S; Parra C
    J Biomed Inform; 2013 Dec; 46(6):977-84. PubMed ID: 23806275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AMBAR - Interactive Alteration annotations for molecular tumor boards.
    Fürstberger A; Ikonomi N; Kestler AMR; Marienfeld R; Schwab JD; Kuhn P; Seufferlein T; Kestler HA
    Comput Methods Programs Biomed; 2023 Oct; 240():107697. PubMed ID: 37441893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical Care Network in the State of Qatar.
    Hijjeh M; Al Shaikh L; Alinier G; Selwood D; Malmstrom F; Hassan IF
    Qatar Med J; 2019; 2019(2):2. PubMed ID: 31763205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virtual Clinical and Precision Medicine Tumor Boards-Cloud-Based Platform-Mediated Implementation of Multidisciplinary Reviews Among Oncology Centers in the COVID-19 Era: Protocol for an Observational Study.
    Blasi L; Bordonaro R; Serretta V; Piazza D; Firenze A; Gebbia V
    JMIR Res Protoc; 2021 Sep; 10(9):e26220. PubMed ID: 34387553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of Treatment Decisions in Multidisciplinary Oncology Meetings: A Quantitative Observational Study.
    Soukup T; Lamb BW; Sarkar S; Arora S; Shah S; Darzi A; Green JS; Sevdalis N
    Ann Surg Oncol; 2016 Dec; 23(13):4410-4417. PubMed ID: 27380047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Practice and Impact of Multidisciplinary Tumor Boards on Patient Management: A Prospective Study.
    Charara RN; Kreidieh FY; Farhat RA; Al-Feghali KA; Khoury KE; Haydar A; Nassar L; Berjawi G; Shamseddine A; El Saghir NS
    J Glob Oncol; 2017 Jun; 3(3):242-249. PubMed ID: 28717766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Framework for Implementing and Tracking a Molecular Tumor Board at a National Cancer Institute-Designated Comprehensive Cancer Center.
    Jain NM; Schmalz L; Cann C; Holland A; Osterman T; Lang K; Wiesner GL; Pal T; Lovly C; Stricker T; Micheel C; Balko JM; Johnson DB; Park BH; Iams W
    Oncologist; 2021 Nov; 26(11):e1962-e1970. PubMed ID: 34390291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extending cBioPortal for Therapy Recommendation Documentation in Molecular Tumor Boards: Development and Usability Study.
    Renner C; Reimer N; Christoph J; Busch H; Metzger P; Boerries M; Ustjanzew A; Boehm D; Unberath P
    JMIR Med Inform; 2023 Dec; 11():e50017. PubMed ID: 38079196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The NCI All Ireland Cancer Conference.
    Johnston PG; Daly PA; Liu E
    Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioinformatics for precision oncology.
    Singer J; Irmisch A; Ruscheweyh HJ; Singer F; Toussaint NC; Levesque MP; Stekhoven DJ; Beerenwinkel N
    Brief Bioinform; 2019 May; 20(3):778-788. PubMed ID: 29272324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bridging therapeutic opportunities: a survey by the Italian molecular tumor board workgroup of Alliance Against Cancer.
    Ciliberto G; Canfora M; Terrenato I; Agnoletto C; Agustoni F; Amoroso L; Baldassarre G; Curigliano G; Delmonte A; De Luca A; Fiorentino M; Gregorc V; Ibrahim T; Lazzari C; Mastronuzzi A; Pronzato P; Santoro A; Scambia G; Tommasi S; Vingiani A; Giacomini P; De Maria R
    J Exp Clin Cancer Res; 2022 Oct; 41(1):305. PubMed ID: 36245005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Capacity building for pediatric neuro-oncology in Pakistan- a project by my child matters program of Foundation S.
    Mushtaq N; Qureshi BM; Javed G; Sheikh NA; Bakhshi SK; Laghari AA; Enam SA; Anwar SSM; Hilal K; Kabir A; Ahmad A; Goraya A; Mistry AS; Rashid A; Maaz AUR; Munawar MA; Khan AA; Bashir F; Hashmi H; Saeed K; Khandwala K; Rehman L; Dewan MC; Khan MS; Karim MU; Shaheen N; Zia N; Yasmeen N; Mahmood R; Memon RAR; Kirmani S; Resham S; Kadri S; Riaz S; Hamid SA; Ghafoor T; Imam U; Mushtaq YR; Rana ZA; Bouffet E; Minhas K
    Front Oncol; 2024; 14():1325167. PubMed ID: 38487721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Collaborative, Multidisciplinary Evaluation of Cancer Variants Through Virtual Molecular Tumor Boards Informs Local Clinical Practices.
    Rao S; Pitel B; Wagner AH; Boca SM; McCoy M; King I; Gupta S; Park BH; Warner JL; Chen J; Rogan PK; Chakravarty D; Griffith M; Griffith OL; Madhavan S
    JCO Clin Cancer Inform; 2020 Jul; 4():602-613. PubMed ID: 32644817
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.